Unity Biotechnology, Inc. Proceeds from Long-Term Debt Issued
Unity Biotechnology, Inc. reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2023-03-15
- Unity Biotechnology, Inc. proceeds from issuance of long-term debt for the quarter ending 2021-12-31 was $0.00.
- Unity Biotechnology, Inc. proceeds from issuance of long-term debt for the quarter ending 2020-12-31 was $0.00.
- Unity Biotechnology, Inc. proceeds from issuance of long-term debt for fiscal 2022 was $0.00.
- Unity Biotechnology, Inc. proceeds from issuance of long-term debt for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Unity Biotechnology, Inc. proceeds from issuance of long-term debt for fiscal 2020 was $24.55M.
- Unity Biotechnology, Inc. proceeds from issuance of long-term debt for fiscal 2019 was $0.00.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-15 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $0.00 10-K · filed 2023-03-15 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $24.55M 10-K · filed 2023-03-15 | |
| 2020-09-30 | $24.55M 10-Q · filed 2021-11-10 | ||
| 2019-12-31 | $0.00 10-K · filed 2022-03-15 | ||
| 2018-12-31 | $0.00 10-K · filed 2021-03-23 |